These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2795604

  • 1. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
    Liu Y, Mellin C, Björk L, Svensson B, Csöregh I, Helander A, Kenne L, Andén NE, Hacksell U.
    J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
    [Abstract] [Full Text] [Related]

  • 2. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
    Mellin C, Vallgårda J, Nelson DL, Björk L, Yu H, Andén NE, Csöregh I, Arvidsson LE, Hacksell U.
    J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
    [Abstract] [Full Text] [Related]

  • 3. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L, Höök BB, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [Abstract] [Full Text] [Related]

  • 4. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE, Karlén A, Norinder U, Kenne L, Sundell S, Hacksell U.
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [Abstract] [Full Text] [Related]

  • 5. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S.
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099
    [Abstract] [Full Text] [Related]

  • 15. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
    Höök BB, Cortizo L, Johansson AM, Westlind-Danielsson A, Mohell N, Hacksell U.
    J Med Chem; 1996 Sep 27; 39(20):4036-43. PubMed ID: 8831769
    [Abstract] [Full Text] [Related]

  • 16. Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties.
    Wikström H, Andersson B, Svensson A, Humber LG, Asselin AA, Svensson K, Ekman A, Carlsson A, Nilsson I, Chidester C.
    J Med Chem; 1989 Oct 27; 32(10):2273-6. PubMed ID: 2571729
    [Abstract] [Full Text] [Related]

  • 17. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S.
    J Med Chem; 1987 Jul 27; 30(7):1135-44. PubMed ID: 3599021
    [Abstract] [Full Text] [Related]

  • 18. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P, Lesourd M, Comoy E.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353
    [Abstract] [Full Text] [Related]

  • 19. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 10; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 20. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M.
    J Pharmacol Exp Ther; 1993 Feb 10; 264(2):863-72. PubMed ID: 8094756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.